نتایج جستجو برای: free survival

تعداد نتایج: 801940  

Journal: :بینا 0
محمدعلی جوادی ma javadi ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم سپهر فیضی s feizi ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم محمدرضا جعفری نسب mr jafarinasab ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم فرید کریمیان f karimian ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم لیلا غیاثیان l ghiasian ophthalmic research center, shahid beheshti university of medical sciences, tehran, iranتهران- پاسداران- بوستان نهم- خیابان پایدارفرد (خیابان امیر ابراهیمی)- پلاک 23- مرکز تحقیقات چشم

purpose: to compare clinical outcomes of two methods of corneal transplantation, penetrating keratoplasty (pk) versus lamellar keratoplasty (lk), in patients with delayed-onset mustard gas keratitis (mgk). methods: in this retrospective, comparative, interventional case series, 78 eyes of 55 victims of chemical warfare with delayed-onset mustard gas keratopathy who underwent pk or lk were enrol...

Journal: :Asian Pacific journal of cancer prevention : APJCP 2013
Xue-Qing Wei Xing Li Xiao-Jie Xin Zhong-Sheng Tong Sheng Zhang

OBJECTIVES To compare the clinicalpathological features and prognosis between premenopausal breast cancer patients aged of <35 and ≥35 years old. METHODS The clinical data and survival status of 1498 cases premenopausal operable breast cancer treated in our hospital from 2002.1 to 2004. 12 were collected, 118 cases were aged <35. They were divided into 4 groups: Luminal A, Luminal B, HER2-pos...

2016
Kyung Don Yoo Clara Tammy Kim Myoung-Hee Kim Junhyug Noh Gunhee Kim Ho Kim Jung Nam An Jae Yoon Park Hyunjeong Cho Kyoung Hoon Kim Hyunwook Kim Dong-Ryeol Ryu Dong Ki Kim Chun Soo Lim Yon Su Kim Jung Pyo Lee

Data regarding kidney transplantation (KT) and dialysis outcomes are rare in Asian populations. In the present study, we evaluated the clinical outcomes associated with KT using claims data from the Korean national public health insurance program. Among the 35,418 adult patients with incident dialysis treated between 2005 and 2008 in Korea, 1539 underwent KT. An optimal balanced risk set matchi...

2015
Hao Sun Shasha Du Guixiang Liao Xiao Xie Chen Ren Ya Wei Yuan Shihan He.

Temozolomide (TMZ) is an oral alkylating agent with established effects on the central nervous system of glioblastoma (GBM) patients. Clinical trials have demonstrated a significant impact on overall survival (OS) with TMZ. Ever since, several TMZ regimens have been designed to improve treatment efficacy by increasing the cumulative dose per cycle. We report a meta-analysis to systematically ev...

2017
Carmen Balaña Jaume Capellades Estela Pineda Anna Estival Josep Puig Sira Domenech Eugenia Verger Teresa Pujol Maria Martinez-García Laura Oleaga JoseMaria Velarde Carlos Mesia Rafael Fuentes Jordi Marruecos Sonia Del Barco Salvador Villà Cristina Carrato Oscar Gallego Miguel Gil-Gil Jordi Craven-Bartle Francesc Alameda

We explored predictive factors of pseudoprogression (PsP) and its impact on prognosis in a retrospective series of uniformly treated glioblastoma patients. Patients were classified as having PsP, early progression (eP) or neither (nP). We examined potential associations with clinical, molecular, and basal imaging characteristics and compared overall survival (OS), progression-free survival (PFS...

2018
Zhenya Jia Jian Zhang Zhonghua Wang Biyun Wang Leiping Wang Jun Cao Zhonghua Tao Xichun Hu

Serum lactate dehydrogenase (LDH) level is predictive of prognosis in various malignancies. Nevertheless, the association between the prognosis of patients with advanced triple-negative breast cancer (TNBC) and LDH is not well understood. This explorative and retrospective study was conducted to clarify the issue. We found that abnormal baseline LDH levels (> 250 IU/L) were significantly associ...

Journal: :Haematologica 2007
Leo Kager Thomas Lion Andishe Attarbaschi Margit Koenig Sabine Strehl Oskar A Haas Michael N Dworzak Martin Schrappe Helmut Gadner Georg Mann

Lessons from the analysis of children with TCF3-PBX1 ALL could help to identify treatment components essential for this leukemia subtype. Of 859 children with ALL who were treated in ALL-BFM trials in Austria, 31 (3.6%) had a TCF3-PBX1 ALL. The 5-year event-free survival rate for these 31 patients was 90%+/-5%. Patients with TCF3-PBX1 ALL treated on the ALL-BFM 86 trial had a poorer outcome tha...

2016
Enrique Espinosa Virtudes Soriano Josep Malvehy Alfonso Berrocal Purificación Martínez de Prado María Quindós Ainara Soria Iván Márquez-Rodas Isabel Palacio Pablo Cerezuela Guillermo López-Vivanco Lorenzo Alonso Elia Samaniego Ana Ballesteros Teresa Puértolas Rodrigo Díaz-Beveridge Luis de la Cruz-Merino Rafael López Castro Rafael López López Kendall Stevinson Patricia del Barrio Maria V. Tornamira Vicente Guillém Salvador Martín-Algarra

Adjuvant interferon-α2b (IFN-α2b) has been studied extensively in clinical trials, but there have been few studies of real-world use. The aim of this study is to describe the IFN-α2b real-world patterns in patients with high-risk melanoma in Spain. This was a retrospective and multicentre chart review study of an unselected cohort of patients with melanoma at high risk for relapse (stage IIB/II...

Journal: :American journal of clinical oncology 2014
Jason A Call Mihir Naik Fausto J Rodriguez Caterina Giannini Wenting Wu Jan C Buckner Ian F Parney Nadia N Laack

OBJECTIVE To assess the survival and role of adjuvant chemotherapy in adult medulloblastoma. METHODS We reviewed outcomes of 66 patients (aged 18 y or more; median age, 33 y) with medulloblastoma. Forty-four (67%) patients had M0 disease, 9 had M1-M4, and 13 had MX. Thirty-one patients each for whom risk stratification was available were classified as high risk or standard risk. Fifty-six pat...

Journal: :Journal of the National Cancer Institute 2011
Lawrence Rubinstein Michael Leblanc Malcolm A Smith

Historically, phase II trials in oncology were generally single armed, constructed to distinguish between a tumor response rate felt to indicate a lack of promise (often 5%) and a rate that would indicate potential benefit (often 20%), with a one-sided type I error rate of 5%–10% and a type II error rate of 10%–20% (1). The dominant use of this design was based on the premise that an agent that...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید